Press Сentre
Наши новости
"NeuroNet is not just a field of science, but a full-fledged industry, where human-machine interaction technologies become the basis for new products and services. Confidence in the future requires not only innovation, but also responsible implementation, competent risk management, and active support for universities and entrepreneurs."
Andrey ...
25.12.2025
On December 9-12, the IV International Infectious Diseases Forum was held at the Sechenov University Congress Center in Moscow. As part of the scientific program of the event, a satellite symposium with international participation "Treatment of patients with chronic viral hepatitis C: new opportunities and prospects" was held with the support of ...
19.12.2025
Participants of the discussion " Domestic pharmaceutical innovations: how to get a world-class high-tech company " in the format of a TED conference, they shared their opinion on whether science can exist without innovation and what is the role of education in the development of innovation.
The event was moderated by an advisor to the General ...
05.12.2025
Moscow, July 16, 2025—Andrey Aleksandrovich Ivashchenko, Chairman of ChemRar Group’s Board of Directors and Head of the Expert Group on “New entrepreneurship types based on advanced technologies (NTI TDK),” received the inaugural national “People Change the Country” award from the Agency for Strategic Initiatives (ASI) for his contributions to ...
18.07.2025
On June 18, 2025, the “Drug Safety” forum hosted a strategic session titled “Technologies Ahead of Time: An Innovative Path for Russia’s Pharmaceutical Industry,” featuring Deputy Minister of Industry and Trade Ekaterina Priezzheva, Deputy Minister of Health Sergey Glagolev, Deputy Head of the Federal Antimonopoly Service Timofey Nizhegorodtsev, ...
04.07.2025
On June 19–20, 2025, Moscow hosted the IV National Expert Council on Viral Hepatitis Elimination—a key industry event that brought together leading specialists in the diagnosis, treatment, and prevention of viral hepatitis from Russia and abroad, as well as representatives of government authorities, pharmaceutical companies, and patient ...
03.07.2025
Avineiro, a company of the ChemRar group, the owner of the registration certificate for the drug Aviandr®, announces that the active ingredient of the drug has been assigned the international non-proprietary name (INN) Maritupirdine. This is an official recognition of the uniqueness and innovation of the Russian molecule and its inclusion in the ...
18.06.2025
CDRI Production Company (ChemRar Group) has successfully confirmed its compliance with GMP standards
The Chemical Diversity Research Institute (CDRI LLC , part of the ChemRar Group, Khimki, Moscow Region) has successfully passed the inspection of the Ministry of Industry and Trade of the Russian Federation and received an updated GMP certificate, confirming the current license for the production of medicines for medical use.
During the ...
26.05.2025
On May 19, 2025, as part of the celebration of the Day of the Pharmaceutical Worker of Russia, established last year by the Ministry of Industry and Trade of the Russian Federation, the first solemn ceremony was held to award pharmaceutical industry workers to the management staff of pharmaceutical companies, representatives of industry ...
19.05.2025
The expert believes that the first signs of degradation have appeared in the industry. To ensure real technological sovereignty it is necessary to replace 9% of INN of own innovative drugs. Such targets were announced at the meeting of the Expert Council in the State Duma, dedicated to the problems o pharma innovations development in 2025-2036.
...
14.02.2025
“HIV Infection: Transformation of Approaches and Effective Balance” IV All-Russian Congress with International Participation was held on December 19-20 in Moscow at the Analytical Center under the Government of the Russian Federation.
Andrey Ivashchenko, the Chairman of the Board of Directors of ChemRar Group took part in the business program ...
28.12.2024
On October 7, 2024, at the Gelendzhik Arena, “Development of Innovative Drugs As Condition for Technological Sovereignty of the Russian Federation in Pharmaceuticals” panel discussion was held within the framework of the Biotechmed-2024 Forum. The panel discussion was prepared with the support of ChemRar Group of Companies and the Innovative ...
25.10.2024
Публикации в печатных и электронных СМИ
Видео
Фото
